Yunnan Baiyao Group Co Ltd

SHE:000538 China Drug Manufacturers - Specialty & Generic
Market Cap
$13.81 Billion
CN¥101.33 Billion CNY
Market Cap Rank
#2567 Global
#170 in China
Share Price
CN¥56.79
Change (1 day)
+0.87%
52-Week Range
CN¥55.00 - CN¥60.24
All Time High
CN¥15689.57
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China. The company offers health products; drugs; chemical raw materials, chemical preparations, sales of chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines, biological products, medical devices, health food, food, beverages, special labor protection products, production and sales … Read more

Yunnan Baiyao Group Co Ltd (000538) - Net Assets

Latest net assets as of September 2025: CN¥39.82 Billion CNY

Based on the latest financial reports, Yunnan Baiyao Group Co Ltd (000538) has net assets worth CN¥39.82 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥53.34 Billion) and total liabilities (CN¥13.53 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥39.82 Billion
% of Total Assets 74.64%
Annual Growth Rate 23.94%
5-Year Change 1.36%
10-Year Change 187.31%
Growth Volatility 64.35

Yunnan Baiyao Group Co Ltd - Net Assets Trend (1991–2024)

This chart illustrates how Yunnan Baiyao Group Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Yunnan Baiyao Group Co Ltd (1991–2024)

The table below shows the annual net assets of Yunnan Baiyao Group Co Ltd from 1991 to 2024.

Year Net Assets Change
2024-12-31 CN¥38.87 Billion -2.60%
2023-12-31 CN¥39.91 Billion +3.58%
2022-12-31 CN¥38.53 Billion +0.24%
2021-12-31 CN¥38.43 Billion +0.23%
2020-12-31 CN¥38.34 Billion +0.64%
2019-12-31 CN¥38.10 Billion +91.24%
2018-12-31 CN¥19.92 Billion +9.81%
2017-12-31 CN¥18.14 Billion +14.51%
2016-12-31 CN¥15.84 Billion +17.12%
2015-12-31 CN¥13.53 Billion +19.77%
2014-12-31 CN¥11.30 Billion +25.10%
2013-12-31 CN¥9.03 Billion +28.33%
2012-12-31 CN¥7.04 Billion +26.65%
2011-12-31 CN¥5.56 Billion +25.84%
2010-12-31 CN¥4.41 Billion +21.62%
2009-12-31 CN¥3.63 Billion +13.91%
2008-12-31 CN¥3.19 Billion +123.66%
2007-12-31 CN¥1.42 Billion +24.28%
2006-12-31 CN¥1.15 Billion +28.29%
2005-12-31 CN¥893.64 Million +20.71%
2004-12-31 CN¥740.30 Million +14.21%
2003-12-31 CN¥648.17 Million +23.41%
2002-12-31 CN¥525.21 Million +10.82%
2001-12-31 CN¥473.92 Million +10.84%
2000-12-31 CN¥427.59 Million +4.19%
1999-12-31 CN¥410.41 Million +46.67%
1998-12-31 CN¥279.81 Million +12.84%
1997-12-31 CN¥247.96 Million +17.93%
1996-12-31 CN¥210.25 Million +4.70%
1995-12-31 CN¥200.81 Million +9.14%
1994-12-31 CN¥184.00 Million +12.04%
1993-12-31 CN¥164.23 Million +367.75%
1992-12-31 CN¥35.11 Million +7.71%
1991-12-31 CN¥32.60 Million --

Equity Component Analysis

This analysis shows how different components contribute to Yunnan Baiyao Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1698133938500.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥16.98 Billion 43.73%
Common Stock CN¥1.78 Billion 4.59%
Other Comprehensive Income CN¥2.59 Billion 6.66%
Other Components CN¥17.48 Billion 45.01%
Total Equity CN¥38.83 Billion 100.00%

Yunnan Baiyao Group Co Ltd Competitors by Market Cap

The table below lists competitors of Yunnan Baiyao Group Co Ltd ranked by their market capitalization.

Company Market Cap
Ryman Hospitality Properties Inc
NYSE:RHP
 		$5.59 Billion
Shin Kong Financial Holding Co Ltd
TW:2888
 		$5.59 Billion
Orica Ltd
AU:ORI
 		$5.59 Billion
VAXCYTE INC. DL -001
F:5VA
 		$5.60 Billion
Tongling Nonferrous Metals Group Co Ltd
SHE:000630
 		$5.58 Billion
Infratil Limited
PINK:IFUUF
 		$5.58 Billion
Mineral Resources Ltd
AU:MIN
 		$5.58 Billion
ESAB Corp
NYSE:ESAB
 		$5.58 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Yunnan Baiyao Group Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 39,879,122,031 to 38,831,946,424, a change of -1,047,175,607 (-2.6%).
  • Net income of 4,749,415,503 contributed positively to equity growth.
  • Dividend payments of 5,943,519,160 reduced retained earnings.
  • Other comprehensive income increased equity by 73,632,843.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥4.75 Billion +12.23%
Dividends Paid CN¥5.94 Billion -15.31%
Other Comprehensive Income CN¥73.63 Million +0.19%
Other Changes CN¥73.30 Million +0.19%
Total Change CN¥- -2.63%

Book Value vs Market Value Analysis

This analysis compares Yunnan Baiyao Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.61x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 1634.59x to 2.61x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1991-12-31 CN¥0.03 CN¥56.79 x
1992-12-31 CN¥0.04 CN¥56.79 x
1993-12-31 CN¥0.18 CN¥56.79 x
1994-12-31 CN¥0.20 CN¥56.79 x
1995-12-31 CN¥0.21 CN¥56.79 x
1996-12-31 CN¥0.22 CN¥56.79 x
1997-12-31 CN¥0.24 CN¥56.79 x
1998-12-31 CN¥0.27 CN¥56.79 x
1999-12-31 CN¥0.40 CN¥56.79 x
2000-12-31 CN¥0.42 CN¥56.79 x
2001-12-31 CN¥0.45 CN¥56.79 x
2002-12-31 CN¥0.49 CN¥56.79 x
2003-12-31 CN¥0.62 CN¥56.79 x
2004-12-31 CN¥0.72 CN¥56.79 x
2005-12-31 CN¥0.88 CN¥56.79 x
2006-12-31 CN¥0.79 CN¥56.79 x
2007-12-31 CN¥1.02 CN¥56.79 x
2008-12-31 CN¥2.37 CN¥56.79 x
2009-12-31 CN¥2.46 CN¥56.79 x
2010-12-31 CN¥3.02 CN¥56.79 x
2011-12-31 CN¥3.80 CN¥56.79 x
2012-12-31 CN¥4.82 CN¥56.79 x
2013-12-31 CN¥6.20 CN¥56.79 x
2014-12-31 CN¥7.68 CN¥56.79 x
2015-12-31 CN¥9.21 CN¥56.79 x
2016-12-31 CN¥10.77 CN¥56.79 x
2017-12-31 CN¥12.37 CN¥56.79 x
2018-12-31 CN¥11.08 CN¥56.79 x
2019-12-31 CN¥21.25 CN¥56.79 x
2020-12-31 CN¥21.24 CN¥56.79 x
2021-12-31 CN¥21.22 CN¥56.79 x
2022-12-31 CN¥24.38 CN¥56.79 x
2023-12-31 CN¥22.31 CN¥56.79 x
2024-12-31 CN¥21.75 CN¥56.79 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Yunnan Baiyao Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 12.23%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 11.86%
  • • Asset Turnover: 0.76x
  • • Equity Multiplier: 1.36x
  • Recent ROE (12.23%) is below the historical average (16.48%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1991 12.25% 10.72% 0.63x 1.82x CN¥733.08K
1992 18.13% 14.19% 0.71x 1.80x CN¥2.85 Million
1993 8.06% 22.69% 0.33x 1.07x CN¥-3.18 Million
1994 12.94% 40.03% 0.30x 1.09x CN¥5.40 Million
1995 8.75% 22.26% 0.32x 1.23x CN¥-2.50 Million
1996 11.37% 25.59% 0.36x 1.23x CN¥2.88 Million
1997 11.61% 19.50% 0.42x 1.42x CN¥3.56 Million
1998 11.38% 17.49% 0.47x 1.39x CN¥3.48 Million
1999 8.89% 14.44% 0.30x 2.02x CN¥-4.17 Million
2000 12.41% 6.09% 1.00x 2.03x CN¥9.41 Million
2001 18.00% 8.35% 1.07x 2.02x CN¥33.39 Million
2002 20.20% 8.51% 1.20x 1.99x CN¥47.31 Million
2003 19.47% 8.46% 1.29x 1.79x CN¥55.31 Million
2004 25.48% 9.35% 1.44x 1.89x CN¥104.11 Million
2005 28.02% 9.41% 1.53x 1.95x CN¥148.14 Million
2006 25.83% 8.50% 1.46x 2.08x CN¥166.82 Million
2007 25.00% 8.18% 1.44x 2.13x CN¥202.07 Million
2008 14.84% 8.13% 1.16x 1.57x CN¥151.70 Million
2009 16.86% 8.42% 1.19x 1.68x CN¥245.61 Million
2010 20.98% 9.19% 1.32x 1.73x CN¥484.80 Million
2011 21.80% 10.70% 1.24x 1.64x CN¥655.38 Million
2012 22.52% 11.46% 1.29x 1.52x CN¥880.12 Million
2013 25.71% 14.68% 1.23x 1.43x CN¥1.42 Billion
2014 22.41% 13.32% 1.15x 1.46x CN¥1.39 Billion
2015 20.63% 13.36% 1.08x 1.44x CN¥1.43 Billion
2016 18.57% 13.03% 0.91x 1.56x CN¥1.35 Billion
2017 17.44% 12.93% 0.88x 1.54x CN¥1.34 Billion
2018 17.66% 12.93% 0.89x 1.54x CN¥1.52 Billion
2019 11.03% 14.10% 0.60x 1.31x CN¥389.92 Million
2020 14.50% 16.85% 0.59x 1.45x CN¥1.71 Billion
2021 7.34% 7.71% 0.70x 1.37x CN¥-1.02 Billion
2022 7.79% 8.22% 0.68x 1.38x CN¥-849.24 Million
2023 10.27% 10.47% 0.73x 1.35x CN¥105.87 Million
2024 12.23% 11.86% 0.76x 1.36x CN¥866.22 Million

Industry Comparison

This section compares Yunnan Baiyao Group Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $765,281,731
  • Average return on equity (ROE) among peers: -24.97%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Yunnan Baiyao Group Co Ltd (000538) CN¥39.82 Billion 12.25% 0.34x $5.59 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078) $52.15 Million 21.80% 0.58x $623.66 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $765.24 Million 1.30% 0.72x $325.92 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $78.32 Million 0.00% 1.98x $3.03 Billion
Wedge Industrial Co Ltd (000534) $1.24 Billion 8.20% 0.96x $1.75 Billion
Hainan Haiyao Co Ltd (000566) $590.38 Million -258.34% 9.36x $713.60 Million
Tus Pharmaceutical Group Co Ltd (000590) $184.11 Million -46.59% 2.19x $317.60 Million
Northeast Pharmaceutical Group Co Ltd (000597) $1.57 Billion 22.73% 1.61x $426.40 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $2.06 Billion 23.61% 0.46x $2.04 Billion
Renhe Pharmacy Co Ltd (000650) $338.74 Million 2.59% 1.24x $777.45 Million